Treatment of hyperuricaemia and gout

Clinical Medicine - Tập 13 Số 4 - Trang 400-403 - 2013
Edward Roddy1, Michael Doherty2
1Arthritis Research UK Primary Care Centre, Research Institute for Primary Care & Health Sciences, Keele University, Keele, UK
2#N# 2University of Nottingham, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Roddy, 2010, Epidemiology of gout, Arthritis Res Ther, 12, 223, 10.1186/ar3199

Schlesinger, 2002, Local ice therapy during bouts of acute gouty arthritis, J Rheumatol, 29, 331

Zhang, 2006, EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT), Ann Rheum Dis, 65, 1312, 10.1136/ard.2006.055269

Jordan, 2007, British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout, Rheumatology, 46, 1372, 10.1093/rheumatology/kem056a

Ahern, 1987, Does colchicine work? The results of the first controlled study in acute gout, Aust N Z J Med, 17, 301, 10.1111/j.1445-5994.1987.tb01232.x

2013

Terkeltaub, 2010, High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study, Arthritis Rheum, 62, 1060, 10.1002/art.27327

Trifirò, 2013, Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study, Ann Rheum Dis, 72, 694, 10.1136/annrheumdis-2011-201254

Li-Yu, 2001, Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout, ?J Rheumatol, 28, 577

Shoji, 2004, A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy, Arthritis Rheum, 51, 321, 10.1002/art.20405

Perez-Ruiz, 2002, Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout, Arthritis Rheum, 47, 356, 10.1002/art.10511

Becker, 2005, Febuxostat compared with -allopurinol in patients with hyperuricemia and gout, N Engl J Med, 353, 2450, 10.1056/NEJMoa050373

2008

14 Electronic Medicines Compendium. Summary of product characteristics: adenuric film-coated tablets, 2013. www.medicines.org.uk/emc/medicine/22830/SPC/Adenuric+film-coated+tablets/ [Accessed 5 June 2013].

Takahashi, 2003, Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism, Ann Rheum Dis, 62, 572, 10.1136/ard.62.6.572

Fam, 2001, Efficacy and safety of desensitization to allopurinol following cutaneous reactions, Arthritis Rheum, 44, 231, 10.1002/1529-0131(200101)44:1<231::AID-ANR30>3.0.CO;2-7

Borstad, 2004, Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis, J Rheumatol, 31, 2429

Martinon, 2006, Gout-associated uric acid crystals activate the NALP3 inflammasome, Nature, 440, 237, 10.1038/nature04516

Sundy, 2011, Efficacy and tolerability of pegloticase for the -treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials, JAMA, 306, 711, 10.1001/jama.2011.1169